Legal status in the United States

Is Fragment 176-191 legal?

Read at FDA, DEA and WADAPublished by PepVault

Fragment 176-191 has no FDA-approved product, is not a federally controlled substance, and is banned in sport (WADA names it under S2.2.3), as of November 18, 2026.

Fragment 176-191 at a glance

CheckStatus, read Nov 18, 2026
FDA approvalNot approved
CompoundingNot named on FDA’s lists
DEA scheduleNot controlled
Sport (WADA)Banned, named (S2.2.3)

FDA approval

Fragment 176-191 (hGH 176-191) has no FDA-approved product: Drugs@FDA lists no application for it.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

FDA’s compounding lists don’t name it: not in any of the three 503A categories on FDA’s list updated May 14, 2026, not on FDA’s category 2 page, and not on the 503B bulks list.

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

WADA bans it at all times, in and out of competition: the 2026 list names “hGH 176-191” under S2.2.3, as a growth hormone fragment.

The source: “growth hormone fragments, e.g. AOD-9604 and hGH 176-191”

How it is sold when it isn’t approved

FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

The source: falsely labeled “for research purposes” or “not for human consumption.”

What this means and doesn’t

This page reports what the agencies’ own pages said about Fragment 176-191 in the United States when we read them on November 18, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Fragment 176-191 FDA approved?

    Fragment 176-191 (hGH 176-191) has no FDA-approved product: Drugs@FDA lists no application for it.

  • Is Fragment 176-191 a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Fragment 176-191 banned in sport?

    WADA bans it at all times, in and out of competition: the 2026 list names “hGH 176-191” under S2.2.3, as a growth hormone fragment.

  • What does FDA say about compounding Fragment 176-191?

    FDA’s compounding lists don’t name it: not in any of the three 503A categories on FDA’s list updated May 14, 2026, not on FDA’s category 2 page, and not on the 503B bulks list.

  • What does FDA say about the “research use only” label?

    FDA has warned companies that sold unapproved GLP-1 drugs labeled “for research purposes” or “not for human consumption” to consumers with dosing instructions, and calls that label false. FDA’s page names GLP-1 drugs; a research label is not an FDA approval of any kind.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo